Matthew D Galsky


Ontology type: schema:Person     


Person Info

NAME

Matthew D

SURNAME

Galsky

Publications in SciGraph latest 50 shown

  • 2019-01 SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer in WORLD JOURNAL OF UROLOGY
  • 2018-12 EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer in NATURE COMMUNICATIONS
  • 2018-11 Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer in WORLD JOURNAL OF UROLOGY
  • 2018-11 Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR in ONCOGENE
  • 2018-09-01 Current Role of Checkpoint Inhibitors in Urologic Cancers in GENITOURINARY CANCERS
  • 2018-07 Resistance to prostate-cancer treatment is driven by immune cells in NATURE
  • 2017-12 Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-12 Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-11-28 Bladder cancer in 2017: Advancing care through genomics and immune checkpoint blockade in NATURE REVIEWS UROLOGY
  • 2017-03 Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer in WORLD JOURNAL OF UROLOGY
  • 2017-01 The role of GATA2 in lethal prostate cancer aggressiveness in NATURE REVIEWS UROLOGY
  • 2016-01 Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit in WORLD JOURNAL OF UROLOGY
  • 2015-12 A robust blood gene expression-based prognostic model for castration-resistant prostate cancer in BMC MEDICINE
  • 2015-12 Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies in TRIALS
  • 2015-12 Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2015-12 A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-06 Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2015-03 Systemic therapy—differentiating the achievable from the achieved in NATURE REVIEWS UROLOGY
  • 2015 Chemotherapy in UPPER TRACT UROTHELIAL CARCINOMA
  • 2015 Management of Metastatic Bladder Tumours in UROLOGICAL ONCOLOGY
  • 2014-09 Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis in TARGETED ONCOLOGY
  • 2014-09 Targeting cancer stem cells to suppress acquired chemotherapy resistance in ONCOGENE
  • 2014-09 Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-12 Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis in WORLD JOURNAL OF UROLOGY
  • 2013-10 Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis in JOURNAL OF HUMAN HYPERTENSION
  • 2013-10 Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States in WORLD JOURNAL OF UROLOGY
  • 2013-09 Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2013-06 Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors in BRITISH JOURNAL OF CANCER
  • 2012-04 Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2010-09 Cabazitaxel in NATURE REVIEWS DRUG DISCOVERY
  • 2010-04 Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics in INVESTIGATIONAL NEW DRUGS
  • 2008 Management of Metastatic Bladder Cancer in UROLOGICAL ONCOLOGY
  • 2007-06 Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma in INVESTIGATIONAL NEW DRUGS
  • 2007-03 High-dose bicalutamide after radiotherapy for locally advanced prostate cancer: a standard of care? in NATURE REVIEWS UROLOGY
  • 2007 Chemotherapy for Bladder Cancer in UROLOGICAL CANCERS IN CLINICAL PRACTICE
  • 2005 Chemotherapy for Bladder Cancer in UROLOGICAL CANCERS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.59734.3c", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21107.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.214458.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.36425.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416167.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.420754.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.477771.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.478132.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.478088.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.266102.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.428254.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419849.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418722.a", 
            "type": "Organization"
          }
        ], 
        "familyName": "Galsky", 
        "givenName": "Matthew D", 
        "id": "sg:person.0674341075.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674341075.72"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T13:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_1015.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0674341075.72'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0674341075.72'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0674341075.72'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0674341075.72'


     

    This table displays all metadata directly associated to this object as RDF triples.

    50 TRIPLES      10 PREDICATES      28 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0674341075.72 schema:affiliation Ndc57d94d1f50440aa7e70e65dd576c8e
    2 https://www.grid.ac/institutes/grid.21107.35
    3 https://www.grid.ac/institutes/grid.214458.e
    4 https://www.grid.ac/institutes/grid.240145.6
    5 https://www.grid.ac/institutes/grid.266102.1
    6 https://www.grid.ac/institutes/grid.36425.36
    7 https://www.grid.ac/institutes/grid.416167.3
    8 https://www.grid.ac/institutes/grid.418722.a
    9 https://www.grid.ac/institutes/grid.419849.9
    10 https://www.grid.ac/institutes/grid.420754.0
    11 https://www.grid.ac/institutes/grid.428254.d
    12 https://www.grid.ac/institutes/grid.477771.5
    13 https://www.grid.ac/institutes/grid.478088.b
    14 https://www.grid.ac/institutes/grid.478132.b
    15 https://www.grid.ac/institutes/grid.48336.3a
    16 https://www.grid.ac/institutes/grid.51462.34
    17 https://www.grid.ac/institutes/grid.5386.8
    18 https://www.grid.ac/institutes/grid.65499.37
    19 schema:familyName Galsky
    20 schema:givenName Matthew D
    21 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674341075.72
    22 schema:sdDatePublished 2019-03-07T13:11
    23 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    24 schema:sdPublisher Nb9541e20e2e34ddbafba5d1610a5e6fe
    25 sgo:license sg:explorer/license/
    26 sgo:sdDataset persons
    27 rdf:type schema:Person
    28 Nb9541e20e2e34ddbafba5d1610a5e6fe schema:name Springer Nature - SN SciGraph project
    29 rdf:type schema:Organization
    30 Ndc57d94d1f50440aa7e70e65dd576c8e schema:affiliation https://www.grid.ac/institutes/grid.59734.3c
    31 sgo:isCurrent true
    32 rdf:type schema:OrganizationRole
    33 https://www.grid.ac/institutes/grid.21107.35 schema:Organization
    34 https://www.grid.ac/institutes/grid.214458.e schema:Organization
    35 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    36 https://www.grid.ac/institutes/grid.266102.1 schema:Organization
    37 https://www.grid.ac/institutes/grid.36425.36 schema:Organization
    38 https://www.grid.ac/institutes/grid.416167.3 schema:Organization
    39 https://www.grid.ac/institutes/grid.418722.a schema:Organization
    40 https://www.grid.ac/institutes/grid.419849.9 schema:Organization
    41 https://www.grid.ac/institutes/grid.420754.0 schema:Organization
    42 https://www.grid.ac/institutes/grid.428254.d schema:Organization
    43 https://www.grid.ac/institutes/grid.477771.5 schema:Organization
    44 https://www.grid.ac/institutes/grid.478088.b schema:Organization
    45 https://www.grid.ac/institutes/grid.478132.b schema:Organization
    46 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    47 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    48 https://www.grid.ac/institutes/grid.5386.8 schema:Organization
    49 https://www.grid.ac/institutes/grid.59734.3c schema:Organization
    50 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...